Verdelis Investments
04/29/2026 | Press release | Archived content
EcoPhage, Verdelis Portfolio Company, Continues to Expand R&D-Driven Portfolio
EcoPhage, a Verdelis Investments portfolio company, continues to expand its R&D-driven portfolio.
In late April 2026, EcoPhage, a leader in the development and commercialization of sustainable phage-based biopesticides for bacterial plant diseases, announced the submission of its product EcoStraw® to the U.S. EPA for regulatory approval. EcoStraw is designed to control the plant disease Angular Leaf Spot in strawberries through a targeted, foliar-applied, preventative solution. EcoStraw marks the company's fourth product submission to the EPA.
Verdelis Investments published this content on April 29, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 23, 2026 at 07:00 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]